DE60310526D1 - Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion - Google Patents

Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion

Info

Publication number
DE60310526D1
DE60310526D1 DE60310526T DE60310526T DE60310526D1 DE 60310526 D1 DE60310526 D1 DE 60310526D1 DE 60310526 T DE60310526 T DE 60310526T DE 60310526 T DE60310526 T DE 60310526T DE 60310526 D1 DE60310526 D1 DE 60310526D1
Authority
DE
Germany
Prior art keywords
ivabradine
pharmaceutical composition
containing pharmaceutical
oral dispersion
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60310526T
Other languages
English (en)
Other versions
DE60310526T2 (de
Inventor
Patrick Wuthrich
Herve Rolland
Marc Julien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS filed Critical Laboratoires Servier SAS
Application granted granted Critical
Publication of DE60310526D1 publication Critical patent/DE60310526D1/de
Publication of DE60310526T2 publication Critical patent/DE60310526T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DE60310526T 2002-01-23 2003-01-22 Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion Expired - Lifetime DE60310526T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0200791A FR2834896B1 (fr) 2002-01-23 2002-01-23 Composition pharmaceutique orodispersible d'ivabradine
FR0200791 2002-01-23
PCT/FR2003/000198 WO2003061662A1 (fr) 2002-01-23 2003-01-22 Composition pharmaceutique orodispersible d'ivabradine

Publications (2)

Publication Number Publication Date
DE60310526D1 true DE60310526D1 (de) 2007-02-01
DE60310526T2 DE60310526T2 (de) 2007-10-25

Family

ID=27589555

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60310526T Expired - Lifetime DE60310526T2 (de) 2002-01-23 2003-01-22 Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion

Country Status (28)

Country Link
US (2) US20050106238A1 (de)
EP (1) EP1474152B1 (de)
JP (1) JP4500052B2 (de)
KR (1) KR100613550B1 (de)
CN (1) CN1278688C (de)
AR (1) AR038206A1 (de)
AT (1) ATE348619T1 (de)
AU (1) AU2003215706B2 (de)
BR (1) BRPI0307056B1 (de)
CA (1) CA2473203C (de)
CY (1) CY1108854T1 (de)
DE (1) DE60310526T2 (de)
DK (1) DK1474152T3 (de)
EA (1) EA007681B1 (de)
ES (1) ES2278165T3 (de)
FR (1) FR2834896B1 (de)
GE (1) GEP20063820B (de)
HK (1) HK1076741A1 (de)
MA (1) MA27102A1 (de)
MX (1) MXPA04007199A (de)
NO (1) NO333698B1 (de)
NZ (1) NZ533842A (de)
PL (1) PL204938B1 (de)
PT (1) PT1474152E (de)
SI (1) SI1474152T1 (de)
UA (1) UA78278C2 (de)
WO (1) WO2003061662A1 (de)
ZA (1) ZA200405129B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2868777B1 (fr) * 2004-04-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CA2617519A1 (en) * 2005-08-23 2007-03-01 Astellas Pharma Inc. Agent for treating atrial fibrillation
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2911279B1 (fr) * 2007-01-11 2009-03-06 Servier Lab Utilisation de l'ivabradine pour l'obtention de medicaments destines au traitement de la dysfonction endotheliale
WO2010128525A2 (en) 2009-05-04 2010-11-11 Dinesh Shantilal Patel A formulation of ivabradine for treating the cardiovascular disease
WO2011157720A2 (en) * 2010-06-14 2011-12-22 Ratiopharm Gmbh Ivabradine-containing pharmaceutical composition with modified release
CN103393611B (zh) * 2013-08-06 2015-08-19 南京正大天晴制药有限公司 一种盐酸伊伐布雷定片剂及其制备方法
WO2016102423A1 (en) * 2014-12-22 2016-06-30 Ratiopharm Gmbh Composition comprising ivabradine in a dissolved form
GR1008821B (el) 2015-06-11 2016-08-01 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου
CN106265582A (zh) * 2016-08-31 2017-01-04 辰欣药业股份有限公司 一种盐酸伊伐布雷定片及其制备工艺
WO2021001601A1 (en) * 2019-07-01 2021-01-07 Orion Corporation Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT376147B (de) * 1980-12-15 1984-10-10 Gergely Gerhard Verfahren und vorrichtung zum granulieren eines pulvergemisches
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
DE3506276C1 (de) * 1985-02-22 1986-04-24 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Direkttablettiermittel
JP3253127B2 (ja) * 1991-06-07 2002-02-04 帝國製薬株式会社 生理活性ポリペプチド含有製剤
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2710265B1 (fr) * 1993-09-22 1995-10-20 Adir Composition pharmaceutique bioadhésive pour la libération contrôlée de principes actifs.
PL187160B1 (pl) * 1994-01-31 2004-05-31 Yamanouchi Pharma Co Ltd Sposób wytwarzania rozpuszczalnej wewnątrzustnie formowanej tłocznie wypraski
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
EP1007083A1 (de) * 1997-05-09 2000-06-14 Feronpatent Limited Stabilisierung von wässrigen interferon-lösungen zur herstellung von sublingualen tabletten
DK1058538T3 (da) * 1998-03-06 2002-10-21 Eurand Int Hurtigt desintegrerende tabletter
JP2983973B1 (ja) * 1998-10-13 1999-11-29 大正薬品工業株式会社 口腔内速崩壊性固形製剤
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2001058944A (ja) * 1999-06-18 2001-03-06 Takeda Chem Ind Ltd 速崩壊性固形製剤
DE60036205T2 (de) * 2000-07-27 2008-05-21 Roquette Frères Granulat bestehend aus Stärke und Laktose
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
FR2818552B1 (fr) * 2000-12-26 2003-02-07 Servier Lab Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible

Also Published As

Publication number Publication date
MA27102A1 (fr) 2004-12-20
CA2473203C (fr) 2010-08-17
NZ533842A (en) 2005-08-26
US20100267693A1 (en) 2010-10-21
UA78278C2 (en) 2007-03-15
GEP20063820B (en) 2006-05-10
FR2834896B1 (fr) 2004-02-27
EA200400927A1 (ru) 2004-12-30
PL370161A1 (en) 2005-05-16
NO333698B1 (no) 2013-08-26
DE60310526T2 (de) 2007-10-25
CA2473203A1 (fr) 2003-07-31
CY1108854T1 (el) 2014-07-02
DK1474152T3 (da) 2007-04-10
SI1474152T1 (sl) 2007-04-30
MXPA04007199A (es) 2004-10-29
JP2005523893A (ja) 2005-08-11
BRPI0307056B1 (pt) 2015-06-30
BR0307056A (pt) 2004-10-26
US20050106238A1 (en) 2005-05-19
CN1278688C (zh) 2006-10-11
WO2003061662A1 (fr) 2003-07-31
ZA200405129B (en) 2005-08-31
ATE348619T1 (de) 2007-01-15
PL204938B1 (pl) 2010-02-26
CN1622809A (zh) 2005-06-01
HK1076741A1 (en) 2006-01-27
FR2834896A1 (fr) 2003-07-25
AR038206A1 (es) 2005-01-05
AU2003215706B8 (en) 2003-09-02
EA007681B1 (ru) 2006-12-29
KR100613550B1 (ko) 2006-08-16
KR20040075366A (ko) 2004-08-27
EP1474152A1 (de) 2004-11-10
PT1474152E (pt) 2007-02-28
JP4500052B2 (ja) 2010-07-14
ES2278165T3 (es) 2007-08-01
EP1474152B1 (de) 2006-12-20
NO20043440L (no) 2004-08-18
AU2003215706B2 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
DE60316323D1 (de) Feste pharmazeutische formulierungen mit telmisartan
DE602004025950D1 (de) Pharmazeutische formulierung mit lanthanum-verbindungen
DE602004016444D1 (de) Azithromycin enthaltende pharmazeutische Zusammensetzungen mit verringerten Nebenwirkungen
ATE336264T1 (de) Dispergierbare pharmazeutische zusammensetzungen
DE60332393D1 (de) Flüssige pharmazeutische zusammensetzung mit pyridonderivaten
ATE324882T1 (de) In der mundhöhle dispergierbare pharmazeutische zusammensetzung mit agomelatin
PT1501534E (pt) Formulacoes farmaceuticas
DE602005012107D1 (de) Pharmazeutische formulierungen mit einem antibioti
DE60118008D1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
DE60127002D1 (de) Pharmazeutische zusammensetzung
DE60209145D1 (de) Pharmazeutische formulierungen mit platinderivaten
DE60312049D1 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen amorphen wirkstoff
DE60210139D1 (de) Pharmazeutische zusammensetzungen enthaltend tegaserod
DE60305728D1 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG
ATE477814T1 (de) Stabile faktor-viii enthaltende pharmazeutische zusammensetzung
ATE415949T1 (de) Pharmazeutische formulierung mit levothyroxin- natrium
DE60310526D1 (de) Ivabradin enthaltende pharmazeutische zusammensetzung mit oraler dispersion
DE60306747D1 (de) Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DE60336999D1 (de) Melatonin enthaltende pharmazeutische formulierung
DE60129238D1 (de) Pharmazeutische zusammensetzung
DE602004024220D1 (de) Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
IS7581A (is) Lyfjasamsetning

Legal Events

Date Code Title Description
8364 No opposition during term of opposition